Cargando…

Challenges for Managed Care from 340B Contract Pharmacies

The federal 340B Drug Pricing Program has expanded rapidly, with important yet still unmeasured impact on both managed care practice and policies. Notably, providers increasingly rely on external, contract pharmacies to extend 340B pricing to a broad set of patients. In 2014, 1 in 4 U.S. retail, mai...

Descripción completa

Detalles Bibliográficos
Autor principal: Fein, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398234/
https://www.ncbi.nlm.nih.gov/pubmed/27003548
http://dx.doi.org/10.18553/jmcp.2016.22.3.197
_version_ 1785084023989600256
author Fein, Adam J.
author_facet Fein, Adam J.
author_sort Fein, Adam J.
collection PubMed
description The federal 340B Drug Pricing Program has expanded rapidly, with important yet still unmeasured impact on both managed care practice and policies. Notably, providers increasingly rely on external, contract pharmacies to extend 340B pricing to a broad set of patients. In 2014, 1 in 4 U.S. retail, mail, and specialty pharmacy locations acted as contract pharmacies for 340B-covered entities. This commentary discusses crucial ways in which 340B growth is affecting managed care pharmacy through formulary rebates, profits from managed care paid prescriptions, disruption of retail pharmacy networks, and reduced generic dispensing rates. Managed care should become more engaged in the discussion on how the 340B program should evolve and offer policy proposals to mitigate the challenges being encountered. There is also an urgent need for objective, transparent research on the 340B program’s costs, benefits, and implications for managed care pharmacy and practice.
format Online
Article
Text
id pubmed-10398234
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103982342023-08-04 Challenges for Managed Care from 340B Contract Pharmacies Fein, Adam J. J Manag Care Spec Pharm Viewpoints The federal 340B Drug Pricing Program has expanded rapidly, with important yet still unmeasured impact on both managed care practice and policies. Notably, providers increasingly rely on external, contract pharmacies to extend 340B pricing to a broad set of patients. In 2014, 1 in 4 U.S. retail, mail, and specialty pharmacy locations acted as contract pharmacies for 340B-covered entities. This commentary discusses crucial ways in which 340B growth is affecting managed care pharmacy through formulary rebates, profits from managed care paid prescriptions, disruption of retail pharmacy networks, and reduced generic dispensing rates. Managed care should become more engaged in the discussion on how the 340B program should evolve and offer policy proposals to mitigate the challenges being encountered. There is also an urgent need for objective, transparent research on the 340B program’s costs, benefits, and implications for managed care pharmacy and practice. Academy of Managed Care Pharmacy 2016-03 /pmc/articles/PMC10398234/ /pubmed/27003548 http://dx.doi.org/10.18553/jmcp.2016.22.3.197 Text en © 2016, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Viewpoints
Fein, Adam J.
Challenges for Managed Care from 340B Contract Pharmacies
title Challenges for Managed Care from 340B Contract Pharmacies
title_full Challenges for Managed Care from 340B Contract Pharmacies
title_fullStr Challenges for Managed Care from 340B Contract Pharmacies
title_full_unstemmed Challenges for Managed Care from 340B Contract Pharmacies
title_short Challenges for Managed Care from 340B Contract Pharmacies
title_sort challenges for managed care from 340b contract pharmacies
topic Viewpoints
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398234/
https://www.ncbi.nlm.nih.gov/pubmed/27003548
http://dx.doi.org/10.18553/jmcp.2016.22.3.197
work_keys_str_mv AT feinadamj challengesformanagedcarefrom340bcontractpharmacies